Equities analysts forecast that Acadia Healthcare Company Inc (NASDAQ:ACHC) will post $759.62 million in sales for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have made estimates for Acadia Healthcare’s earnings, with the highest sales estimate coming in at $775.50 million and the lowest estimate coming in at $713.48 million. Acadia Healthcare reported sales of $742.24 million during the same quarter last year, which would suggest a positive year over year growth rate of 2.3%. The business is expected to issue its next quarterly earnings results on Tuesday, May 7th.
On average, analysts expect that Acadia Healthcare will report full year sales of $3.17 billion for the current fiscal year, with estimates ranging from $3.12 billion to $3.20 billion. For the next year, analysts anticipate that the business will report sales of $3.35 billion, with estimates ranging from $3.27 billion to $3.39 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Acadia Healthcare.
Several equities analysts have recently commented on the company. Robert W. Baird reduced their target price on Acadia Healthcare from $40.00 to $38.00 and set a “neutral” rating for the company in a research note on Monday, March 4th. BidaskClub cut Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Saturday, December 15th. Zacks Investment Research upgraded Acadia Healthcare from a “hold” rating to a “buy” rating and set a $30.00 target price for the company in a research note on Monday, February 18th. Deutsche Bank assumed coverage on Acadia Healthcare in a research note on Thursday, January 3rd. They set a “hold” rating and a $27.00 target price for the company. Finally, TheStreet cut Acadia Healthcare from a “c” rating to a “d” rating in a research note on Friday, March 1st. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and three have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $37.20.
Shares of Acadia Healthcare stock traded up $0.49 on Tuesday, hitting $30.95. 58,710 shares of the company’s stock traded hands, compared to its average volume of 1,308,045. The stock has a market cap of $2.66 billion, a P/E ratio of 13.81, a price-to-earnings-growth ratio of 1.69 and a beta of 0.65. The company has a current ratio of 1.08, a quick ratio of 1.08 and a debt-to-equity ratio of 1.35. Acadia Healthcare has a 52-week low of $24.27 and a 52-week high of $45.35.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Recommended Story: Short Selling Stocks and Day Traders
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.